Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.

Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.

Item

http://www.wikidata.org/entity/Q34154651

Q34154651

about

Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis.Endocervical glandular lesions: controversial aspects and ancillary techniques.p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group.Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection.p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome.p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina.New developments in endocervical glandular lesions.High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.A High Ki67/BCL2 Index Could Predict Lower Disease-Free and Overall Survival in Intestinal-Type Gastric Cancer.High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.[Precancerous lesions of the uterine cervix: morphology and molecular pathology].Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology

P2860

Q25257313-C53FA427-5B9D-47A1-8488-0ADF39020A43 Q34502213-1708C79E-29BA-4E9C-A602-9EDD3F34A01C Q35074701-08D217C2-5130-4FA6-8AE6-B48044A98EC9 Q35588555-9172D99A-D5C2-4228-BDF1-2CE5AE48E127 Q35903625-C6037334-F493-4F51-8BE9-1DC0A61B564C Q36524707-5FE826DB-B54F-4CFB-A6E8-640AD817A6FE Q36748493-F033D805-3D1A-44C1-8560-D739B365DC83 Q36897784-8D9926DE-82B4-4103-ABDF-53FD4175FE89 Q37406427-3815B96A-8BCC-45E9-84A8-67B1101379E7 Q37650660-725A0E63-67FA-4853-90DB-59590CD732D9 Q38058367-379CD106-F3E8-456B-BC97-537F68B5FBA3 Q38414170-5C770004-1E23-4C4E-98A4-13B37FA5F879 Q38418735-F1FBE10F-7AD8-48AC-A1CB-5A4B2EECCB40 Q51106107-DBC5B534-65C1-49C2-8939-D9A1AFAA7AB3 Q51753726-DE3C7CA3-89EB-440B-9C3F-5AF05D2E3AE5 Q53256324-EEFCC2E0-5285-4574-9328-CEA46F624042 Q53281884-0A0CA102-F9D1-4593-B794-E8A87BED98DE Q54647189-2530D9E0-82F7-4E45-96B0-B81D68107EE8 Q57713548-EBBCD55C-53F0-462B-A43F-4AA8DF213A2D

P2860

Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.

Item

http://www.wikidata.org/entity/Q34154651

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu